Wegovy Cost in 2026: Prices and How to Save

If your pharmacy quoted you north of $1,300 for a month of Wegovy, that number is real — and it's also not the price most cash-paying patients end up at. Wegovy cost has moved a lot in the past year: the list price still sits near $1,350 a month, but a string of price cuts, a brand-new pill version, and self-pay options have pulled the actual out-of-pocket number down sharply for people paying without insurance.

Here's what Wegovy actually costs in 2026 — by format, by dose, with and without insurance — and where the real savings are.

How much does Wegovy cost in 2026?

Wegovy (semaglutide) is a once-weekly GLP-1 injection from Novo Nordisk, FDA-approved for chronic weight management and, more recently, for reducing the risk of heart attack and stroke in adults with obesity and existing cardiovascular disease. In early 2026 a daily oral version — the Wegovy pill — joined the lineup as the first oral GLP-1 approved for weight loss.

The sticker price is the same for both: roughly $1,350 per month. That figure is the list price (what the manufacturer sets), and it's the number that shows up when nothing else is applied. Walk into a retail pharmacy with no coverage and no discount, and a month of Wegovy injections typically rings up somewhere between $1,200 and $1,500.

Almost nobody needs to pay that. Between manufacturer self-pay pricing, insurance, and cash-pay networks, the real-world cost lands well below list for most people. The trick is knowing which path applies to you.

Wegovy cost without insurance

The 2026 changes show up most clearly here. A few years ago, "no insurance" basically meant paying full list price. Now there are several legitimate cash routes, and they're competitive.

Manufacturer self-pay (injection). Novo Nordisk sells Wegovy directly to cash-paying patients through its own pharmacy channel. In November 2025 it dropped the established self-pay price from $499 to $349 a month for the standard injection doses (0.25, 0.5, 1, 1.7, and 2.4 mg). New self-pay patients can get the two starter doses for $199 a month for the first couple of fills before stepping up to $349. The high-dose Wegovy HD 7.2 mg pen, approved in early 2026, runs about $399 a month.

Manufacturer self-pay (pill). The oral version is the budget surprise of 2026. Self-pay pricing starts at $149 a month for the 1.5 mg and 4 mg doses, with the higher 9 mg and 25 mg doses around $299 a month. For someone who can't get insurance coverage and does fine on a lower dose, the pill is often the cheapest brand-Wegovy option available.

Cash-pay health networks. Services like CanAmerica Plus list Wegovy on a cash basis — the pen shows around $325 on its pricing calculator, with the final number depending on strength and quantity. For people who don't qualify for manufacturer self-pay, or who want to compare, a cash-pay network is worth pricing out alongside the other options.

What the dose titration means for your cost

Wegovy injections follow a step-up schedule — most people start at 0.25 mg weekly and increase roughly every four weeks (0.25 → 0.5 → 1 → 1.7 → 2.4 mg) until they reach a maintenance dose. The helpful part for budgeting: each carton holds four weekly pens, and the manufacturer's self-pay price is the same across those standard doses. So your monthly cost doesn't climb just because your dose does. The pill follows its own escalation, and its price does step up at the highest tiers.

Wegovy cost with insurance

Coverage is the wild card. When a commercial plan covers Wegovy, the monthly copay can be modest — sometimes well under $100, occasionally close to $0 on generous plans. The problem is that many plans still exclude weight-loss medications, or attach prior-authorization hurdles and BMI requirements.

Two things to check on your specific plan:

• Is Wegovy on the formulary, and at what tier? A covered tier-2 or tier-3 drug means a manageable copay. A non-covered or specialty-tier placement can leave you paying hundreds.
• What indication is covered? Some plans cover Wegovy for cardiovascular risk reduction but not for weight loss alone, which changes whether your prescription goes through.

Medicare is its own situation. It generally doesn't cover medications prescribed solely for weight loss, though coverage can apply when Wegovy is prescribed for an approved indication like reducing cardiovascular risk. If you're on Medicare, confirm the covered indication with your plan before assuming a price.

If your plan denies coverage or quotes a copay higher than the self-pay options above, the cash route may genuinely beat "using your insurance." Run both numbers.

Wegovy pill cost vs. injection cost

The oral Wegovy pill changes the math for a lot of people, so it's worth comparing the two formats side by side.

Format	How it's taken	List price/month	Self-pay starting price
Wegovy injection	Once-weekly shot	~$1,350	$349/mo (standard doses)
Wegovy pill	Once-daily tablet	~$1,350	$149/mo (starter doses)
Wegovy HD 7.2 mg	Once-weekly shot (high dose)	~$1,350	~$399/mo

On paper the pill is cheaper to start, and a daily tablet appeals to anyone who'd rather skip needles. The catch is that the pill and the injection aren't identical clinically — they use different dosing, and weight-loss results in trials aren't a perfect one-to-one match. Don't switch formats to chase a lower price without talking to your prescriber about whether the pill is right for your dose and goals.

The Wegovy pill is also distinct from Rybelsus, the older oral semaglutide tablet that's approved for type 2 diabetes rather than weight loss. Same active ingredient, different products and different approved uses.

Why Wegovy's price changed in 2026

If you priced Wegovy a year ago and got a different number, you're not imagining it. Several things shifted:

• The self-pay injection price fell from $499 to $349 in November 2025, cutting the established cash price by $150 a month.
• The oral Wegovy pill launched in early 2026 after FDA approval in late 2025, adding a lower-cost entry point starting near $149.
• Wegovy HD (7.2 mg) was approved as a higher-dose injection, expanding options for patients who need more.
• The semaglutide shortage ended, which wound down the era of cheap compounded versions (more on that below).

Net effect: more formats, more price tiers, and a lower floor for cash-paying patients than existed even a year ago. It also means older articles quoting "$1,300 a month, period" are out of date.

Is there a generic for Wegovy?

Not yet. Wegovy's active ingredient, semaglutide, is still under patent protection, and no FDA-approved generic is available in the United States. Patent estimates generally point to the early 2030s before generic semaglutide could realistically enter the U.S. market, though legal challenges and settlements can shift those dates.

During the recent shortage, compounding pharmacies were permitted to make semaglutide, which created a window of much cheaper "compounded semaglutide." Now that the FDA considers the shortage resolved, that pathway has largely closed for routine use. Be cautious of any seller still advertising cheap compounded or "research" semaglutide — verify you're dealing with a licensed pharmacy, because counterfeit GLP-1 products have been a documented problem.

How Wegovy compares to other weight-loss drugs on cost

Wegovy isn't the only GLP-1 option, and price can be a legitimate factor in the conversation with your doctor. Here's a rough cash-pay comparison of the major players. Approved uses differ — only Wegovy, Zepbound, and Saxenda are FDA-approved specifically for weight management, while Ozempic and Mounjaro are diabetes drugs sometimes used off-label.

Medication	Active ingredient	Form	Approx. list price/mo	Cash-pay starting point
Wegovy	semaglutide	Weekly injection	~$1,350	from ~$325
Wegovy pill	semaglutide	Daily pill	~$1,350	from ~$149
Zepbound	tirzepatide	Weekly injection	~$1,086	from ~$400
Saxenda	liraglutide	Daily injection	~$1,350	from ~$470 (5 pens)
Ozempic	semaglutide	Weekly injection	~$998	varies by source
Mounjaro	tirzepatide	Weekly injection	~$1,080	varies by source

Zepbound (tirzepatide) is the most direct weight-loss competitor and has posted strong results in head-to-head data. Saxenda (liraglutide) is an older daily injection that's often available at a lower cash price. For diabetes patients, Ozempic and Mounjaro come up frequently. Cost is one input — efficacy, side effects, and your specific health picture matter more, so use the table to start a conversation, not to self-prescribe.

How to save on Wegovy

A few practical moves can meaningfully lower what you pay:

• Compare the pill and the injection. If your prescriber is open to it, the oral version's $149 starting self-pay price can beat the injection's $349 for some patients.
• Price your exact dose across sources. Manufacturer self-pay, a cash-pay network like CanAmerica Plus, and your insurance copay can each win depending on the dose and your plan. Get all three numbers.
• Ask about therapeutic alternatives. A different GLP-1 such as Saxenda may carry a lower cash price for a similar approach — worth raising with your doctor if budget is the sticking point.
• Buy only from licensed, verified pharmacies. A "too cheap" Wegovy offer is a red flag. Counterfeit GLP-1 pens have circulated, and the savings aren't worth the risk.

The bottom line

Wegovy's list price near $1,350 a month is the number to ignore, not the number to plan around. In 2026, cash-paying patients have real options: the manufacturer's self-pay injection at $349, the new oral pill starting around $149, and cash-pay networks listing the pen near $325. The smartest first step is to price your specific prescribed dose across the manufacturer, your insurance, and a cash-pay source — then bring the best number to your doctor. If you want a deeper comparison with the other top weight-loss option, our breakdown of Zepbound vs. Wegovy covers results and cost side by side.

Frequently asked questions

How much does Wegovy cost per month without insurance?

In 2026, self-pay prices generally run from about $149 a month for the starter oral pill to $349 a month for the standard injection through the manufacturer's cash channel. Cash-pay networks list the pen around $325. Full retail without any discount can still reach $1,200–$1,500, so it pays to use one of the lower-cost routes.

Is the Wegovy pill cheaper than the injection?

Often, yes — at least to start. The oral Wegovy pill's self-pay price begins near $149 a month for lower doses, versus $349 for the standard injection. The higher pill doses (9 mg and 25 mg) cost more, around $299. The two formats aren't clinically interchangeable, so talk to your prescriber before switching for price reasons.

Does insurance cover Wegovy?

Some commercial plans cover it, sometimes with a low copay, but many exclude weight-loss drugs or require prior authorization. Medicare typically won't cover Wegovy for weight loss alone, though it may cover an approved indication like cardiovascular risk reduction. Always confirm your formulary tier and covered indication before assuming a price.

Is there a generic version of Wegovy?

No. Semaglutide is still patent-protected, and no FDA-approved generic Wegovy exists in the U.S. yet. Generic competition isn't expected until the early 2030s. Compounded semaglutide, which was available during the shortage, has largely been discontinued now that the shortage is resolved.

Why did Wegovy's price drop in 2026?

Novo Nordisk lowered its established self-pay injection price from $499 to $349 in late 2025, and the launch of the lower-cost oral pill added a cheaper entry point. More formats and price tiers mean cash-paying patients have a lower floor than in prior years.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.